Mark Schiffman - Publications

Affiliations: 
Johns Hopkins University, Baltimore, MD 
Area:
Public Health, Oncology

163 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Wagner S, Roberson D, Boland J, Kreimer AR, Yeager M, Cullen M, Mirabello L, Dunn ST, Walker J, Zuna R, Porras C, Cortes B, Sampson J, Herrero R, Rodriguez AC, ... ... Schiffman M, et al. Evaluation of TypeSeq, a Novel High-Throughput, Low-Cost, Next-Generation Sequencing-Based Assay for Detection of 51 Human Papillomavirus Genotypes. The Journal of Infectious Diseases. PMID 31536132 DOI: 10.1093/infdis/jiz324  0.36
2019 Dawson ET, Wagner S, Roberson D, Yeager M, Boland J, Garrison E, Chanock S, Schiffman M, Raine-Bennett T, Lorey T, Castle PE, Mirabello L, Durbin R. Viral coinfection analysis using a MinHash toolkit. Bmc Bioinformatics. 20: 389. PMID 31299914 DOI: 10.1186/s12859-019-2918-y  0.36
2019 Schiffman M, Hu L, Antani S, Wentzensen N. Response to Pretorius and Belinson. Journal of the National Cancer Institute. PMID 31187134 DOI: 10.1093/jnci/djz119  0.36
2019 Wentzensen N, Clarke MA, Bremer R, Poitras N, Tokugawa D, Goldhoff PE, Castle PE, Schiffman M, Kingery JD, Grewal KK, Locke A, Kinney W, Lorey TS. Clinical Evaluation of Human Papillomavirus Screening With p16/Ki-67 Dual Stain Triage in a Large Organized Cervical Cancer Screening Program. Jama Internal Medicine. PMID 31081870 DOI: 10.1001/jamainternmed.2019.0306  0.36
2019 Landy R, Schiffman M, Sasieni PD, Cheung LC, Katki HA, Rydzak G, Wentzensen N, Poitras NE, Lorey T, Kinney WK, Castle PE. Absolute risks of cervical precancer among women who fulfil exiting guidelines based on HPV and cytology cotesting. International Journal of Cancer. PMID 30861114 DOI: 10.1002/ijc.32268  0.44
2019 Wagner S, Roberson D, Boland J, Yeager M, Cullen M, Mirabello L, Dunn ST, Walker J, Zuna R, Schiffman M, Wentzensen N. Development of the TypeSeq Assay for Detection of 51 HPV Genotypes by Next Generation Sequencing. Journal of Clinical Microbiology. PMID 30814267 DOI: 10.1128/JCM.01794-18  0.36
2019 Clifford GM, Tenet V, Georges D, Alemany L, Pavón MA, Chen Z, Yeager M, Cullen M, Boland JF, Bass S, Steinberg M, Raine-Bennett T, Lorey T, Wentzensen N, Walker J, ... ... Schiffman M, et al. Human Papillomavirus 16 sub-lineage dispersal and cervical cancer risk worldwide: whole viral genome sequences from 7116 HPV16-positive women. Papillomavirus Research (Amsterdam, Netherlands). PMID 30738204 DOI: 10.1016/j.pvr.2019.02.001  0.36
2019 Hu L, Bell D, Antani S, Xue Z, Yu K, Horning MP, Gachuhi N, Wilson B, Jaiswal MS, Befano B, Long LR, Herrero R, Einstein MH, Burk RD, Demarco M, ... ... Schiffman M, et al. An Observational Study of Deep Learning and Automated Evaluation of Cervical Images for Cancer Screening. Journal of the National Cancer Institute. PMID 30629194 DOI: 10.1093/jnci/djy225  0.36
2018 Castle PE, Kinney WK, Xue X, Cheung LC, Gage JC, Poitras NE, Lorey TS, Katki HA, Wentzensen N, Schiffman M. Role of Screening History in Clinical Meaning and Optimal Management of Positive Cervical Screening Results. Journal of the National Cancer Institute. PMID 30576462 DOI: 10.1093/jnci/djy192  0.36
2018 Conrad RD, Liu AH, Wentzensen N, Zhang RR, Dunn ST, Wang SS, Schiffman M, Gold MA, Walker JL, Zuna RE. Cytologic patterns of cervical adenocarcinomas with emphasis on factors associated with underdiagnosis. Cancer Cytopathology. PMID 30351473 DOI: 10.1002/cncy.22055  0.36
2018 Clarke MA, Cheung LC, Castle PE, Schiffman M, Tokugawa D, Poitras N, Lorey T, Kinney W, Wentzensen N. Five-Year Risk of Cervical Precancer Following p16/Ki-67 Dual-Stain Triage of HPV-Positive Women. Jama Oncology. PMID 30325982 DOI: 10.1001/jamaoncol.2018.4270  0.36
2018 Castle PE, Xie X, Xue X, Poitras NE, Lorey TS, Kinney WK, Wentzensen N, Strickler HD, Burger EA, Schiffman M. Impact of human papillomavirus vaccination on the clinical meaning of cervical screening results. Preventive Medicine. PMID 30316878 DOI: 10.1016/j.ypmed.2018.10.001  0.36
2018 Silver MI, Andrews J, Cooper CK, Gage JC, Gold MA, Khan MJ, Massad LS, Parvu V, Perkins RB, Schiffman M, Smith KM, Wentzensen N. Risk of Cervical Intraepithelial Neoplasia 2 or Worse by Cytology, Human Papillomavirus 16/18, and Colposcopy Impression: A Systematic Review and Meta-analysis. Obstetrics and Gynecology. PMID 30095780 DOI: 10.1097/AOG.0000000000002812  0.36
2018 Gravitt PE, Landy R, Schiffman M. How confident can we be in the current guidelines for exiting cervical screening? Preventive Medicine. PMID 29981791 DOI: 10.1016/j.ypmed.2018.07.005  0.44
2018 Safaeian M, Castellsagué X, Hildesheim A, Wacholder S, Schiffman MH, Bozonnat MC, Baril L, Rosillon D. Risk of HPV-16/18 Infections and Associated Cervical Abnormalities in Women Seropositive for Naturally Acquired Antibodies: Pooled Analysis Based on Control Arms of Two Large Clinical Trials. The Journal of Infectious Diseases. PMID 29718393 DOI: 10.1093/infdis/jiy112  0.32
2018 Yu K, Hyun N, Fetterman B, Lorey T, Raine-Bennett TR, Zhang H, Stamps RE, Poitras NE, Wheeler W, Befano B, Gage JC, Castle PE, Wentzensen N, Schiffman M. Automated Cervical Screening and Triage, Based on HPV Testing and Computer-Interpreted Cytology. Journal of the National Cancer Institute. PMID 29659930 DOI: 10.1093/jnci/djy044  0.36
2018 Demarco M, Cheung LC, Kinney WK, Wentzensen N, Lorey TS, Fetterman B, Poitras NE, Befano B, Castle PE, Schiffman M. Low Risk of Cervical Cancer/Precancer Among Most Women Under Surveillance Postcolposcopy. Journal of Lower Genital Tract Disease. 22: 97-103. PMID 29570564 DOI: 10.1097/LGT.0000000000000382  0.36
2018 Demarco M, Carter-Pokras O, Hyun N, Castle PE, He X, Dallal CM, Chen J, Gage JC, Befano B, Fetterman B, Lorey T, Poitras N, Raine-Bennett TR, Wentzensen N, Schiffman M. Validation of an HPV DNA cervical screening test that provides expanded HPV typing. Journal of Clinical Microbiology. PMID 29491018 DOI: 10.1128/JCM.01910-17  0.36
2018 Wentzensen N, Walker J, Smith K, Gold MA, Zuna R, Massad LS, Liu A, Silver MI, Dunn ST, Schiffman M. A prospective study of risk-based colposcopy demonstrates improved detection of cervical precancers. American Journal of Obstetrics and Gynecology. PMID 29462629 DOI: 10.1016/j.ajog.2018.02.009  0.36
2018 Mirabello L, Clarke MA, Nelson CW, Dean M, Wentzensen N, Yeager M, Cullen M, Boland JF, Schiffman M, Burk RD. The Intersection of HPV Epidemiology, Genomics and Mechanistic Studies of HPV-Mediated Carcinogenesis. Viruses. 10. PMID 29438321 DOI: 10.3390/v10020080  0.36
2018 Silver MI, Gage JC, Schiffman M, Fetterman B, Poitras NE, Lorey T, Cheung LC, Katki HA, Locke A, Kinney WK, Castle PE. Clinical outcomes after conservative management of cervical intraepithelial neoplasia grade 2 (CIN2) in women ages 21-39 years. Cancer Prevention Research (Philadelphia, Pa.). PMID 29437696 DOI: 10.1158/1940-6207.CAPR-17-0293  0.36
2018 Clarke MA, Gradíssimo A, Schiffman M, Lam J, Sollecito CC, Fetterman B, Lorey T, Poitras NE, Raine-Bennett T, Castle PE, Wentzensen N, Burk RD. Human Papillomavirus DNA methylation as a biomarker for cervical precancer: Consistency across 12 genotypes and potential impact on management of HPV-positive women. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 29420222 DOI: 10.1158/1078-0432.CCR-17-3251  0.36
2018 Lang Kuhs KA, Lin SW, Hua X, Schiffman M, Burk RD, Rodriguez AC, Herrero R, Abnet CC, Freedman ND, Pinto LA, Hamm D, Robins H, Hildesheim A, Shi J, Safaeian M. T cell receptor repertoire among women who cleared and failed to clear cervical human papillomavirus infection: An exploratory proof-of-principle study. Plos One. 13: e0178167. PMID 29385144 DOI: 10.1371/journal.pone.0178167  0.32
2018 Kreimer AR, Herrero R, Sampson JN, Porras C, Lowy DR, Schiller JT, Schiffman M, Rodriguez AC, Chanock S, Jimenez S, Schussler J, Gail MH, Safaeian M, Kemp TJ, Cortes B, et al. Evidence for single-dose protection by the bivalent HPV vaccine-Review of the Costa Rica HPV vaccine trial and future research studies. Vaccine. PMID 29366703 DOI: 10.1016/j.vaccine.2017.12.078  0.32
2018 Clarke MA, Fetterman B, Cheung LC, Wentzensen N, Gage JC, Katki HA, Befano B, Demarco M, Schussler J, Kinney WK, Raine-Bennett TR, Lorey TS, Poitras NE, Castle PE, Schiffman M. Epidemiologic Evidence That Excess Body Weight Increases Risk of Cervical Cancer by Decreased Detection of Precancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2017753442. PMID 29356609 DOI: 10.1200/JCO.2017.75.3442  0.36
2018 Chen Z, Schiffman M, Herrero R, DeSalle R, Anastos K, Segondy M, Sahasrabuddhe VV, Gravitt PE, Hsing AW, Chan PKS, Burk RD. Classification and evolution of human papillomavirus genome variants: Alpha-5 (HPV26, 51, 69, 82), Alpha-6 (HPV30, 53, 56, 66), Alpha-11 (HPV34, 73), Alpha-13 (HPV54) and Alpha-3 (HPV61). Virology. 516: 86-101. PMID 29331867 DOI: 10.1016/j.virol.2018.01.002  0.44
2018 Wentzensen N, Schiffman M. Accelerating cervical cancer control and prevention. The Lancet. Public Health. 3: e6-e7. PMID 29307389 DOI: 10.1016/S2468-2667(17)30242-6  0.36
2018 Safaeian M, Sampson JN, Pan Y, Porras C, Kemp TJ, Herrero R, Quint W, van Doorn LJ, Schussler J, Lowy DR, Schiller J, Schiffman MT, Rodriguez AC, Gail MH, Hildesheim A, et al. Durability of Protection Afforded by Fewer Doses of the HPV16/18 Vaccine: The CVT Trial. Journal of the National Cancer Institute. 110. PMID 28954299 DOI: 10.1093/jnci/djx158  0.32
2017 Conrad R, Wentzensen N, Zhang RR, Wang S, Schiffman M, Gold M, Walker J, Zuna RE. Distribution of cell types differs in Papanicolaou tests of squamous cell carcinomas and adenocarcinomas. Journal of the American Society of Cytopathology. 6: 10-15. PMID 31042628 DOI: 10.1016/j.jasc.2016.08.003  0.36
2017 Rendle KA, Schiffman M, Cheung LC, Kinney WK, Fetterman B, Poitras NE, Lorey T, Castle PE. Adherence patterns to extended cervical screening intervals in women undergoing human papillomavirus (HPV) and cytology cotesting. Preventive Medicine. PMID 29288782 DOI: 10.1016/j.ypmed.2017.12.023  0.36
2017 Landy R, Cheung LC, Schiffman M, Gage JC, Hyun N, Wentzensen N, Kinney WK, Castle PE, Fetterman B, Poitras NE, Lorey T, Sasieni PD, Katki HA. Challenges in risk estimation using routinely collected clinical data: The example of estimating cervical cancer risks from electronic health-records. Preventive Medicine. PMID 29222045 DOI: 10.1016/j.ypmed.2017.12.004  0.44
2017 Castle PE, Kinney WK, Xue X, Cheung LC, Gage JC, Zhao FH, Fetterman B, Poitras NE, Lorey TS, Wentzensen N, Katki HA, Schiffman M. Effect of Several Negative Rounds of Human Papillomavirus and Cytology Co-testing on Safety Against Cervical Cancer: An Observational Cohort Study. Annals of Internal Medicine. PMID 29181509 DOI: 10.7326/M17-1609  0.36
2017 Schiffman M, Kinney WK, Cheung LC, Gage JC, Fetterman B, Poitras NE, Lorey TS, Wentzensen N, Befano B, Schussler J, Katki HA, Castle PE. Relative Performance of HPV and Cytology Components of Cotesting in Cervical Screening. Journal of the National Cancer Institute. PMID 29145648 DOI: 10.1093/jnci/djx225  0.36
2017 Liu AH, Walker J, Gage JC, Gold MA, Zuna R, Dunn ST, Schiffman M, Wentzensen N. Diagnosis of Cervical Precancers by Endocervical Curettage at Colposcopy of Women With Abnormal Cervical Cytology. Obstetrics and Gynecology. PMID 29112672 DOI: 10.1097/AOG.0000000000002330  0.36
2017 Eldridge RC, Pawlita M, Wilson L, Castle PE, Waterboer T, Gravitt PE, Schiffman M, Wentzensen N. Smoking and subsequent human papillomavirus infection: a mediation analysis. Annals of Epidemiology. PMID 29107447 DOI: 10.1016/j.annepidem.2017.10.004  0.44
2017 Schiffman M, Wentzensen N. Effective use of human papillomavirus testing for cervical cancer screening requires extended intervals to target persistent infections and precancerous lesions. Preventive Medicine. 105: 378-380. PMID 29056320 DOI: 10.1016/j.ypmed.2017.09.010  0.36
2017 Demarco M, Lorey TS, Fetterman B, Cheung LC, Guido RS, Wentzensen N, Kinney WK, Poitras NE, Befano B, Castle PE, Schiffman M. Risks of CIN 2+, CIN 3+, and Cancer by Cytology and Human Papillomavirus Status: The Foundation of Risk-Based Cervical Screening Guidelines. Journal of Lower Genital Tract Disease. 21: 261-267. PMID 28953116 DOI: 10.1097/LGT.0000000000000343  0.36
2017 Waxman AG, Conageski C, Silver MI, Tedeschi C, Stier EA, Apgar B, Huh WK, Wentzensen N, Massad LS, Khan MJ, Mayeaux EJ, Einstein MH, Schiffman MH, Guido RS. ASCCP Colposcopy Standards: How Do We Perform Colposcopy? Implications for Establishing Standards. Journal of Lower Genital Tract Disease. 21: 235-241. PMID 28953112 DOI: 10.1097/LGT.0000000000000336  0.36
2017 Wentzensen N, Schiffman M, Silver MI, Khan MJ, Perkins RB, Smith KM, Gage JC, Gold MA, Conageski C, Einstein MH, Mayeaux EJ, Waxman AG, Huh WK, Massad LS. ASCCP Colposcopy Standards: Risk-Based Colposcopy Practice. Journal of Lower Genital Tract Disease. 21: 230-234. PMID 28953111 DOI: 10.1097/LGT.0000000000000334  0.36
2017 Khan MJ, Werner CL, Darragh TM, Guido RS, Mathews C, Moscicki AB, Mitchell MM, Schiffman M, Wentzensen N, Massad LS, Mayeaux EJ, Waxman AG, Conageski C, Einstein MH, Huh WK. ASCCP Colposcopy Standards: Role of Colposcopy, Benefits, Potential Harms, and Terminology for Colposcopic Practice. Journal of Lower Genital Tract Disease. 21: 223-229. PMID 28953110 DOI: 10.1097/LGT.0000000000000338  0.36
2017 Wentzensen N, Massad LS, Mayeaux EJ, Khan MJ, Waxman AG, Einstein MH, Conageski C, Schiffman MH, Gold MA, Apgar BS, Chelmow D, Choma KK, Darragh TM, Gage JC, Garcia FAR, et al. Evidence-Based Consensus Recommendations for Colposcopy Practice for Cervical Cancer Prevention in the United States. Journal of Lower Genital Tract Disease. 21: 216-222. PMID 28953109 DOI: 10.1097/LGT.0000000000000322  0.36
2017 Mirabello L, Yeager M, Yu K, Clifford GM, Xiao Y, Zhu B, Cullen M, Boland JF, Wentzensen N, Nelson CW, Raine-Bennett T, Chen Z, Bass S, Song L, Yang Q, ... ... Schiffman M, et al. HPV16 E7 Genetic Conservation Is Critical to Carcinogenesis. Cell. 170: 1164-1174.e6. PMID 28886384 DOI: 10.1016/j.cell.2017.08.001  0.36
2017 Cheung LC, Pan Q, Hyun N, Schiffman M, Fetterman B, Castle PE, Lorey T, Katki HA. Mixture models for undiagnosed prevalent disease and interval-censored incident disease: applications to a cohort assembled from electronic health records. Statistics in Medicine. PMID 28660629 DOI: 10.1002/sim.7380  0.36
2017 Castle PE, Kinney WK, Cheung LC, Gage JC, Fetterman B, Poitras NE, Lorey TS, Wentzensen N, Befano B, Schussler J, Katki HA, Schiffman M. Why does cervical cancer occur in a state-of-the-art screening program? Gynecologic Oncology. PMID 28606721 DOI: 10.1016/j.ygyno.2017.06.003  0.36
2017 Fokom Domgue J, Schiffman M, Wentzensen NH, Gage JC, Castle PE, Raine-Bennett TR, Fetterman B, Lorey T, Poitras NE, Befano B, Xie Y, Miachon LS, Dean M. Assessment of a new lower-cost real-time PCR detection assay for high-risk HPV: Useful for cervical screening in limited resource settings? Journal of Clinical Microbiology. PMID 28515214 DOI: 10.1128/JCM.00492-17  0.36
2017 Clarke MA, Luhn P, Gage JC, Bodelon C, Dunn ST, Walker J, Zuna R, Hewitt S, Killian JK, Yan L, Miller A, Schiffman M, Wentzensen N. Discovery and validation of candidate host DNA methylation markers for detection of cervical precancer and cancer. International Journal of Cancer. PMID 28500655 DOI: 10.1002/ijc.30781  0.36
2017 Schiffman M, Wentzensen N, Khan MJ, Castle PE, Chelmow D, Huh WK, Moscicki AB, Stockdale CK, Darragh TM, Silver M, Guido RS. Preparing for the Next Round of ASCCP-Sponsored Cervical Screening and Management Guidelines. Journal of Lower Genital Tract Disease. PMID 28244885 DOI: 10.1097/LGT.0000000000000300  0.36
2017 Tota JE, Struyf F, Merikukka M, Gonzalez P, Kreimer AR, Bi D, Castellsagué X, de Carvalho NS, Garland SM, Harper DM, Karkada N, Peters K, Pope WA, Porras C, Quint W, ... ... Schiffman M, et al. Evaluation of Type Replacement Following HPV16/18 Vaccination: Pooled Analysis of Two Randomized Trials. Journal of the National Cancer Institute. 109. PMID 28132019 DOI: 10.1093/jnci/djw300  0.32
2017 Rodríguez AC, Ávila C, Herrero R, Hildesheim A, Sherman ME, Burk RD, Morales J, Alfaro M, Guillén D, Trejos ME, Vargas RM, Torres G, Schiffman M. Cervical cancer incidence after screening with HPV, cytology, and visual methods: 18-year follow-up of the Guanacaste cohort. International Journal of Cancer. PMID 28120391 DOI: 10.1002/ijc.30614  0.32
2016 Schiffman M, Doorbar J, Wentzensen N, de Sanjosé S, Fakhry C, Monk BJ, Stanley MA, Franceschi S. Carcinogenic human papillomavirus infection. Nature Reviews. Disease Primers. 2: 16086. PMID 27905473 DOI: 10.1038/nrdp.2016.86  0.36
2016 Beachler DC, Tota JE, Silver MI, Kreimer AR, Hildesheim A, Wentzensen N, Schiffman M, Shiels MS. Trends in cervical cancer incidence in younger US women from 2000 to 2013. Gynecologic Oncology. PMID 27894752 DOI: 10.1016/j.ygyno.2016.11.031  0.36
2016 Gage JC, Hunt WC, Schiffman M, Katki HA, Cheung LA, Myers O, Cuzick J, Wentzensen N, Kinney W, Castle PE, Wheeler CM. Similar Risk Patterns After Cervical Screening in Two Large U.S. Populations: Implications for Clinical Guidelines. Obstetrics and Gynecology. PMID 27824767 DOI: 10.1097/AOG.0000000000001721  0.36
2016 Schiffman M, Yu K, Zuna R, Terence Dunn S, Zhang H, Walker J, Gold M, Hyun N, Rydzak G, Katki HA, Wentzensen N. Proof-of-principle study of a novel cervical screening and triage strategy: computer-analyzed cytology to decide which HPV-positive women are likely to have ≥CIN2. International Journal of Cancer. PMID 27696414 DOI: 10.1002/ijc.30456  0.36
2016 Silver MI, Schiffman M, Fetterman B, Poitras NE, Gage JC, Wentzensen N, Lorey T, Kinney WK, Castle PE. The population impact of human papillomavirus/cytology cervical cotesting at 3-year intervals: Reduced cervical cancer risk and decreased yield of precancer per screen. Cancer. PMID 27657992 DOI: 10.1002/cncr.30277  0.36
2016 Schiffman M, Hyun N, Raine-Bennett TR, Katki H, Fetterman B, Gage JC, Cheung LC, Befano B, Poitras N, Lorey T, Castle PE, Wentzensen NH. A Cohort Study of Cervical Screening Using Partial HPV Typing and Cytology Triage. International Journal of Cancer. PMID 27509172 DOI: 10.1002/ijc.30375  0.32
2016 Gage JC, Joste N, Ronnett BM, Stoler M, Hunt WC, Schiffman M, Wheeler CM. Corrigendum to "A comparison of cervical histopathology variability using whole slide digitized images versus glass slides: experience with a statewide registry" [HumAN PatholOGY 2013;44:2542-2548]. Human Pathology. PMID 27141825 DOI: 10.1016/j.humpath.2016.04.001  0.32
2016 Mirabello L, Yeager M, Cullen M, Boland JF, Chen Z, Wentzensen N, Zhang X, Yu K, Yang Q, Mitchell J, Roberson D, Bass S, Xiao Y, Burdett L, Raine-Bennett T, ... ... Schiffman M, et al. HPV16 Sublineage Associations With Histology-Specific Cancer Risk Using HPV Whole-Genome Sequences in 3200 Women. Journal of the National Cancer Institute. 108. PMID 27130930 DOI: 10.1093/jnci/djw100  0.36
2016 Xi LF, Schiffman M, Koutsky LA, Hughes JP, Hulbert A, Shen Z, Galloway DA, Kiviat NB. Variant-Specific Persistence of Infections with Human Papillomavirus Types 31, 33, 45, 56 and 58 and Risk of Cervical Intraepithelial Neoplasia. International Journal of Cancer. PMID 27121353 DOI: 10.1002/ijc.30164  0.32
2016 Liu AH, Gold MA, Schiffman M, Smith KM, Zuna RE, Dunn ST, Gage JC, Walker JL, Wentzensen N. Comparison of Colposcopic Impression Based on Live Colposcopy and Evaluation of Static Digital Images. Journal of Lower Genital Tract Disease. 20: 154-61. PMID 27015261 DOI: 10.1097/LGT.0000000000000194  0.32
2016 Hildesheim A, Gonzalez P, Kreimer AR, Wacholder S, Schussler J, Rodriguez AC, Porras C, Schiffman M, Sidawy M, Schiller JT, Lowy DR, Herrero R. Impact of Human Papillomavirus (HPV) 16 and 18 Vaccination on Prevalent Infections and Rates of Cervical Lesions After Excisional Treatment. American Journal of Obstetrics and Gynecology. PMID 26892991 DOI: 10.1016/j.ajog.2016.02.021  0.32
2016 Zhao FH, Hu SY, Zhang Q, Zhang X, Pan QJ, Zhang WH, Gage JC, Wentzensen N, Castle PE, Qiao YL, Katki HA, Schiffman M. Risk assessment to guide cervical screening strategies in a large chinese population. International Journal of Cancer. Journal International Du Cancer. PMID 26800481 DOI: 10.1002/ijc.30012  0.32
2016 Wentzensen N, Fetterman B, Castle P, Schiffman M, Wood S, Tokugawa D, Bodelon C, Poitras N, Lorey T, Kinney W. Response. Journal of the National Cancer Institute. 108. PMID 26711869 DOI: 10.1093/jnci/djv390  0.32
2016 Schiffman M, Wentzensen N. A Suggested Approach to Simplify and Improve Cervical Screening in the United States. Journal of Lower Genital Tract Disease. 20: 1-7. PMID 26704326 DOI: 10.1097/LGT.0000000000000170  0.36
2016 Beachler DC, Kreimer AR, Schiffman M, Herrero R, Wacholder S, Rodriguez AC, Lowy DR, Porras C, Schiller JT, Quint W, Jimenez S, Safaeian M, Struijk L, Schussler J, Hildesheim A, et al. Multisite HPV16/18 Vaccine Efficacy Against Cervical, Anal, and Oral HPV Infection. Journal of the National Cancer Institute. 108. PMID 26467666 DOI: 10.1093/jnci/djv302  0.32
2015 Bodelon C, Vinokourova S, Sampson JN, den Boon JA, Walker JL, Horswill MA, Korthauer K, Schiffman M, Sherman ME, Zuna RE, Mitchell J, Zhang X, Boland JF, Chaturvedi AK, Dunn T, et al. Chromosomal copy number alterations and HPV integration in cervical precancer and invasive cancer. Carcinogenesis. PMID 26660085 DOI: 10.1093/carcin/bgv171  0.32
2015 Cullen M, Boland JF, Schiffman M, Zhang X, Wentzensen N, Yang Q, Chen Z, Yu K, Mitchell J, Roberson D, Bass S, Burdette L, Machado M, Ravichandran S, Luke B, et al. Deep sequencing of HPV16 genomes: A new high-throughput tool for exploring the carcinogenicity and natural history of HPV16 infection. Papillomavirus Research. 1: 3-11. PMID 26645052 DOI: 10.1016/j.pvr.2015.05.004  0.32
2015 Wentzensen N, Schiffman M, Palmer T, Arbyn M. Triage of HPV positive women in cervical cancer screening. Journal of Clinical Virology : the Official Publication of the Pan American Society For Clinical Virology. PMID 26643050 DOI: 10.1016/j.jcv.2015.11.015  0.32
2015 Castro FA, Koshiol J, Quint W, Wheeler CM, Gillison ML, Vaughan LM, Kleter B, van Doorn LJ, Chaturvedi AK, Hildesheim A, Schiffman M, Wang SS, Zuna RE, Walker JL, Dunn ST, et al. Detection of HPV DNA in paraffin-embedded cervical samples: a comparison of four genotyping methods. Bmc Infectious Diseases. 15: 544. PMID 26607224 DOI: 10.1186/s12879-015-1281-5  0.32
2015 Gage JC, Hunt WC, Schiffman M, Katki HA, Cheung LC, Cuzick J, Myers O, Castle PE, Wheeler CM, Group Author NM. Risk Stratification using Human Papillomavirus Testing among Women with Equivocally Abnormal Cytology: Results from a State-wide Surveillance Program. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 26518316 DOI: 10.1158/1055-9965.EPI-15-0669  0.32
2015 Harari A, Chen Z, Rodríguez AC, Hildesheim A, Porras C, Herrero R, Wacholder S, Panagiotou OA, Befano B, Burk RD, Schiffman M. Cross-protection of the bivalent human papillomavirus (HPV) vaccine against variants of genetically related high-risk HPV infections. The Journal of Infectious Diseases. PMID 26518044 DOI: 10.1093/infdis/jiv519  0.32
2015 Schiffman M, Wentzensen N. Towards therapeutic vaccination against cervical precancer? The Lancet. 386: 2036-2038. PMID 26386539 DOI: 10.1016/S0140-6736(15)00240-8  0.32
2015 Wentzensen N, Fetterman B, Castle PE, Schiffman M, Wood SN, Stiemerling E, Tokugawa D, Bodelon C, Poitras N, Lorey T, Kinney W. p16/Ki-67 Dual Stain Cytology for Detection of Cervical Precancer in HPV-Positive Women. Journal of the National Cancer Institute. 107. PMID 26376685 DOI: 10.1093/jnci/djv257  0.36
2015 Liu X, Schiffman M, Hulbert A, He Z, Shen Z, Koutsky LA, Xi LF. Association of Human Papillomavirus Type 31 DNA Load with Risk of Cervical Intraepithelial Neoplasia Grades 2-3. Journal of Clinical Microbiology. PMID 26292291 DOI: 10.1128/JCM.01279-15  0.32
2015 Schiffman M, Vaughan LM, Raine-Bennett TR, Castle PE, Katki HA, Gage JC, Fetterman B, Befano B, Wentzensen N. A study of HPV typing for the management of HPV-positive ASC-US cervical cytologic results. Gynecologic Oncology. 138: 573-8. PMID 26148763 DOI: 10.1016/j.ygyno.2015.06.040  0.32
2015 Schiffman M, Boyle S, Raine-Bennett T, Katki HA, Gage JC, Wentzensen N, Kornegay JR, Apple R, Aldrich C, Erlich HA, Tam T, Befano B, Burk RD, Castle PE. The Role of Human Papillomavirus Genotyping in Cervical Cancer Screening: A Large-Scale Evaluation of the cobas HPV Test. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 24: 1304-10. PMID 26088703 DOI: 10.1158/1055-9965.EPI-14-1353  0.36
2015 van der Marel J, Rodriguez A, Del Pino M, van Baars R, Jenkins D, van de Sandt MM, Torné A, Ordi J, Ter Harmsel B, Verheijen RH, Schiffman M, Gage JC, Quint WG, Wentzensen N. The Value of Endocervical Curettage in Addition to Biopsies in Women Referred to Colposcopy. Journal of Lower Genital Tract Disease. PMID 26083332 DOI: 10.1097/LGT.0000000000000124  0.32
2015 den Boon JA, Pyeon D, Wang SS, Horswill M, Schiffman M, Sherman M, Zuna RE, Wang Z, Hewitt SM, Pearson R, Schott M, Chung L, He Q, Lambert P, Walker J, et al. Molecular transitions from papillomavirus infection to cervical precancer and cancer: Role of stromal estrogen receptor signaling. Proceedings of the National Academy of Sciences of the United States of America. 112: E3255-64. PMID 26056290 DOI: 10.1073/pnas.1509322112  0.32
2015 Frimer M, Sun C, McAndrew T, Smith B, Harari A, Chen Z, Mirabello L, Wentzensen N, Goldberg GL, Rodriguez AC, Schiffman M, Burk RD. HPV16 CpG methyl-haplotypes are associated with cervix precancer and cancer in the Guanacaste natural history study. Gynecologic Oncology. 138: 94-100. PMID 26001326 DOI: 10.1016/j.ygyno.2015.05.001  0.32
2015 Schiffman M, Wentzensen N. Issues in optimising and standardising the accuracy and utility of the colposcopic examination in the HPV era. Ecancermedicalscience. 9: 530. PMID 25987899 DOI: 10.3332/ecancer.2015.530  0.36
2015 Gonzalez P, Hildesheim A, Herrero R, Katki H, Wacholder S, Porras C, Safaeian M, Jimenez S, Darragh TM, Cortes B, Befano B, Schiffman M, Carvajal L, Palefsky J, Schiller J, et al. Rationale and design of a long term follow-up study of women who did and did not receive HPV 16/18 vaccination in Guanacaste, Costa Rica. Vaccine. 33: 2141-51. PMID 25796338 DOI: 10.1016/j.vaccine.2015.03.015  0.32
2015 Schiffman M, Wentzensen N. Transitioning to a new era in cervical cancer screening Gynecologic Oncology. 136: 175-177. PMID 25680631 DOI: 10.1016/j.ygyno.2015.01.538  0.32
2015 Huh WK, Ault KA, Chelmow D, Davey DD, Goulart RA, Garcia FAR, Kinney WK, Massad LS, Mayeaux EJ, Saslow D, Schiffman M, Wentzensen N, Lawson HW, Einstein MH. Use of primary high-risk human papillomavirus testing for cervical cancer screening: Interim clinical guidance Gynecologic Oncology. 136: 178-182. PMID 25579107 DOI: 10.1016/j.ygyno.2014.12.022  0.32
2015 Huh WK, Ault KA, Chelmow D, Davey DD, Goulart RA, Garcia FA, Kinney WK, Massad LS, Mayeaux EJ, Saslow D, Schiffman M, Wentzensen N, Lawson HW, Einstein MH. Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance. Journal of Lower Genital Tract Disease. 19: 91-6. PMID 25574659 DOI: 10.1097/LGT.0000000000000103  0.32
2015 Huh WK, Ault KA, Chelmow D, Davey DD, Goulart RA, Garcia FA, Kinney WK, Massad LS, Mayeaux EJ, Saslow D, Schiffman M, Wentzensen N, Lawson HW, Einstein MH. Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance. Obstetrics and Gynecology. 125: 330-7. PMID 25569009 DOI: 10.1097/AOG.0000000000000669  0.32
2015 Gage JC, Schiffman M, Katki HA, Castle PE, Fetterman B, Wentzensen N, Poitras NE, Lorey T, Cheung LC, Kinney WK. Response. Journal of the National Cancer Institute. 107: 390. PMID 25542966 DOI: 10.1093/jnci/dju390  0.32
2015 Porras C, Hildesheim A, González P, Schiffman M, Rodríguez AC, Wacholder S, Jiménez S, Quint W, Guillen D, Kreimer AR, Herrero R. Performance of self-collected cervical samples in screening for future precancer using human papillomavirus DNA testing. Journal of the National Cancer Institute. 107: 400. PMID 25479804 DOI: 10.1093/jnci/dju400  0.32
2015 Wentzensen N, Walker JL, Gold MA, Smith KM, Zuna RE, Mathews C, Dunn ST, Zhang R, Moxley K, Bishop E, Tenney M, Nugent E, Graubard BI, Wacholder S, Schiffman M. Multiple biopsies and detection of cervical cancer precursors at colposcopy. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 33: 83-9. PMID 25422481 DOI: 10.1200/JCO.2014.55.9948  0.32
2015 van der Marel J, Berkhof J, Ordi J, Torné A, Del Pino M, van Baars R, Schiffman M, Wentzensen N, Jenkins D, Quint WG. Attributing oncogenic human papillomavirus genotypes to high-grade cervical neoplasia: which type causes the lesion? The American Journal of Surgical Pathology. 39: 496-504. PMID 25353286 DOI: 10.1097/PAS.0000000000000342  0.32
2015 Gage JC, Katki HA, Schiffman M, Fetterman B, Poitras NE, Lorey T, Cheung LC, Castle PE, Kinney WK. Age-stratified 5-year risks of cervical precancer among women with enrollment and newly detected HPV infection. International Journal of Cancer. 136: 1665-71. PMID 25136967 DOI: 10.1002/ijc.29143  0.32
2015 Mirabello L, Frimer M, Harari A, McAndrew T, Smith B, Chen Z, Wentzensen N, Wacholder S, Castle PE, Raine-Bennett T, Schiffman M, Burk RD. HPV16 methyl-haplotypes determined by a novel next-generation sequencing method are associated with cervical precancer. International Journal of Cancer. Journal International Du Cancer. 136: E146-53. PMID 25081507 DOI: 10.1002/ijc.29119  0.32
2014 Xi LF, Schiffman M, Koutsky LA, Hughes JP, Winer RL, Mao C, Hulbert A, Lee SK, Shen Z, Kiviat NB. Lineages of oncogenic human papillomavirus types other than type 16 and 18 and risk for cervical intraepithelial neoplasia. Journal of the National Cancer Institute. 106. PMID 25217779 DOI: 10.1093/jnci/dju270  0.32
2014 Lang Kuhs KA, Porras C, Schiller JT, Rodriguez AC, Schiffman M, Gonzalez P, Wacholder S, Ghosh A, Li Y, Lowy DR, Kreimer AR, Poncelet S, Schussler J, Quint W, van Doorn LJ, et al. Effect of different human papillomavirus serological and DNA criteria on vaccine efficacy estimates. American Journal of Epidemiology. 180: 599-607. PMID 25139208 DOI: 10.1093/aje/kwu168  0.32
2014 Wentzensen N, Fetterman B, Tokugawa D, Schiffman M, Castle PE, Wood SN, Stiemerling E, Poitras N, Lorey T, Kinney W. Interobserver reproducibility and accuracy of p16/Ki-67 dual-stain cytology in cervical cancer screening Cancer Cytopathology. 122: 914-920. PMID 25132656 DOI: 10.1002/cncy.21473  0.32
2014 Campos NG, Burger EA, Sy S, Sharma M, Schiffman M, Rodriguez AC, Hildesheim A, Herrero R, Kim JJ. An updated natural history model of cervical cancer: derivation of model parameters. American Journal of Epidemiology. 180: 545-55. PMID 25081182 DOI: 10.1093/aje/kwu159  0.32
2014 Gage JC, Katki HA, Schiffman M, Castle PE, Fetterman B, Poitras NE, Lorey T, Cheung LC, Behrens C, Sharma A, Zhao FH, Cuzick J, Yang ZH, Kinney WK. The low risk of precancer after a screening result of human papillomavirus-negative/atypical squamous cells of undetermined significance papanicolaou and implications for clinical management. Cancer Cytopathology. 122: 842-50. PMID 25045058 DOI: 10.1002/cncy.21463  0.32
2014 Gage JC, Schiffman M, Katki HA, Castle PE, Fetterman B, Wentzensen N, Poitras NE, Lorey T, Cheung LC, Kinney WK. Reassurance against future risk of precancer and cancer conferred by a negative human papillomavirus test. Journal of the National Cancer Institute. 106. PMID 25038467 DOI: 10.1093/jnci/dju153  0.32
2014 Lang Kuhs KA, Gonzalez P, Rodriguez AC, van Doorn LJ, Schiffman M, Struijk L, Chen S, Quint W, Lowy DR, Porras C, DelVecchio C, Jimenez S, Safaeian M, Schiller JT, Wacholder S, et al. Reduced prevalence of vulvar HPV16/18 infection among women who received the HPV16/18 bivalent vaccine: a nested analysis within the Costa Rica Vaccine Trial. The Journal of Infectious Diseases. 210: 1890-9. PMID 24958910 DOI: 10.1093/infdis/jiu357  0.32
2014 Zhao L, Wentzensen N, Zhang RR, Dunn ST, Gold MA, Wang SS, Schiffman M, Walker JL, Zuna RE. Factors associated with reduced accuracy in Papanicolaou tests for patients with invasive cervical cancer. Cancer Cytopathology. 122: 694-701. PMID 24888458 DOI: 10.1002/cncy.21443  0.32
2014 Sahasrabuddhe VV, Gravitt PE, Dunn ST, Robbins D, Brown D, Allen RA, Eby YJ, Smith KM, Zuna RE, Zhang RR, Gold MA, Schiffman M, Walker JL, Castle PE, Wentzensen N. Evaluation of clinical performance of a novel urine-based HPV detection assay among women attending a colposcopy clinic. Journal of Clinical Virology : the Official Publication of the Pan American Society For Clinical Virology. 60: 414-7. PMID 24881489 DOI: 10.1016/j.jcv.2014.04.016  0.32
2014 Robbins HA, Li Y, Porras C, Pawlita M, Ghosh A, Rodriguez AC, Schiffman M, Wacholder S, Kemp TJ, Gonzalez P, Schiller J, Lowy D, Esser M, Matys K, Quint W, et al. Glutathione S-transferase L1 multiplex serology as a measure of cumulative infection with human papillomavirus. Bmc Infectious Diseases. 14: 120. PMID 24588945 DOI: 10.1186/1471-2334-14-120  0.32
2014 Wilson L, Pawlita M, Castle PE, Waterboer T, Sahasrabuddhe V, Gravitt PE, Schiffman M, Wentzensen N. Seroprevalence of 8 oncogenic human papillomavirus genotypes and acquired immunity against reinfection. The Journal of Infectious Diseases. 210: 448-55. PMID 24569064 DOI: 10.1093/infdis/jiu104  0.32
2014 Wentzensen N, Schiffman M. Filling a gap in cervical cancer screening programmes The Lancet Oncology. 15: 249-251. PMID 24529698 DOI: 10.1016/S1470-2045(14)70073-7  0.32
2014 Robbins HA, Kemp TJ, Porras C, Rodriguez AC, Schiffman M, Wacholder S, Gonzalez P, Schiller J, Lowy D, Poncelet S, Esser M, Matys K, Hildesheim A, Pinto LA, Herrero R, et al. Comparison of antibody responses to human papillomavirus vaccination as measured by three assays. Frontiers in Oncology. 3: 328. PMID 24455487 DOI: 10.3389/fonc.2013.00328  0.32
2014 Sahasrabuddhe VV, Gravitt PE, Dunn ST, Brown D, Allen RA, Eby YJ, Smith K, Zuna RE, Zhang RR, Gold MA, Schiffman M, Walker JL, Castle PE, Wentzensen N. Comparison of human papillomavirus detections in urine, vulvar, and cervical samples from women attending a colposcopy clinic. Journal of Clinical Microbiology. 52: 187-92. PMID 24197879 DOI: 10.1128/JCM.01623-13  0.32
2014 Wentzensen N, Nason M, Schiffman M, Dodd L, Hunt WC, Wheeler CM. No evidence for synergy between human papillomavirus genotypes for the risk of high-grade squamous intraepithelial lesions in a large population-based study. The Journal of Infectious Diseases. 209: 855-64. PMID 24179110 DOI: 10.1093/infdis/jit577  0.32
2014 Koshiol J, Sklavos M, Wentzensen N, Kemp T, Schiffman M, Dunn ST, Wang SS, Walker JL, Safaeian M, Zuna RE, Hildesheim A, Pfeiffer RM, Pinto LA. Evaluation of a multiplex panel of immune-related markers in cervical secretions: a methodologic study. International Journal of Cancer. Journal International Du Cancer. 134: 411-25. PMID 23824624 DOI: 10.1002/ijc.28354  0.32
2013 Bosch FX, Broker TR, Forman D, Moscicki AB, Gillison ML, Doorbar J, Stern PL, Stanley M, Arbyn M, Poljak M, Cuzick J, Castle PE, Schiller JT, Markowitz LE, Fisher WA, ... ... Schiffman M, et al. Comprehensive control of human papillomavirus infections and related diseases. Vaccine. 31: H1-31. PMID 24332295 DOI: 10.1016/j.vaccine.2013.10.003  0.32
2013 Bosch FX, Broker TR, Forman D, Moscicki AB, Gillison ML, Doorbar J, Stern PL, Stanley M, Arbyn M, Poljak M, Cuzick J, Castle PE, Schiller JT, Markowitz LE, Fisher WA, ... ... Schiffman M, et al. Comprehensive control of human papillomavirus infections and related diseases. Vaccine. 31: G1-31. PMID 24331817 DOI: 10.1016/j.vaccine.2013.10.002  0.32
2013 Bosch FX, Broker TR, Forman D, Moscicki AB, Gillison ML, Doorbar J, Stern PL, Stanley M, Arbyn M, Poljak M, Cuzick J, Castle PE, Schiller JT, Markowitz LE, Fisher WA, ... ... Schiffman M, et al. Comprehensive control of human papillomavirus infections and related diseases. Vaccine. 31: F1-31. PMID 24331745 DOI: 10.1016/j.vaccine.2013.10.001  0.32
2013 Bosch FX, Broker TR, Forman D, Moscicki AB, Gillison ML, Doorbar J, Stern PL, Stanley M, Arbyn M, Poljak M, Cuzick J, Castle PE, Schiller JT, Markowitz LE, Fisher WA, ... ... Schiffman M, et al. Comprehensive control of human papillomavirus infections and related diseases. Vaccine. 31: I1-31. PMID 24229716 DOI: 10.1016/j.vaccine.2013.07.026  0.32
2013 Safaeian M, Porras C, Pan Y, Kreimer A, Schiller JT, Gonzalez P, Lowy DR, Wacholder S, Schiffman M, Rodriguez AC, Herrero R, Kemp T, Shelton G, Quint W, van Doorn LJ, et al. Durable antibody responses following one dose of the bivalent human papillomavirus L1 virus-like particle vaccine in the Costa Rica Vaccine Trial. Cancer Prevention Research (Philadelphia, Pa.). 6: 1242-50. PMID 24189371 DOI: 10.1158/1940-6207.CAPR-13-0203  0.32
2013 Gage JC, Joste N, Ronnett BM, Stoler M, Hunt WC, Schiffman M, Wheeler CM. A comparison of cervical histopathology variability using whole slide digitized images versus glass slides: experience with a statewide registry. Human Pathology. 44: 2542-8. PMID 24075599 DOI: 10.1016/j.humpath.2013.06.015  0.32
2013 Lang Kuhs KA, Gonzalez P, Struijk L, Castro F, Hildesheim A, van Doorn LJ, Rodriguez AC, Schiffman M, Quint W, Lowy DR, Porras C, Delvecchio C, Katki HA, Jimenez S, Safaeian M, et al. Prevalence of and risk factors for oral human papillomavirus among young women in Costa Rica. The Journal of Infectious Diseases. 208: 1643-52. PMID 24014882 DOI: 10.1093/infdis/jit369  0.32
2013 Chen Z, Schiffman M, Herrero R, DeSalle R, Anastos K, Segondy M, Sahasrabuddhe VV, Gravitt PE, Hsing AW, Burk RD. Evolution and taxonomic classification of alphapapillomavirus 7 complete genomes: HPV18, HPV39, HPV45, HPV59, HPV68 and HPV70. Plos One. 8: e72565. PMID 23977318 DOI: 10.1371/journal.pone.0072565  0.32
2013 Herrero R, Quint W, Hildesheim A, Gonzalez P, Struijk L, Katki HA, Porras C, Schiffman M, Rodriguez AC, Solomon D, Jimenez S, Schiller JT, Lowy DR, van Doorn LJ, Wacholder S, et al. Reduced prevalence of oral human papillomavirus (HPV) 4 years after bivalent HPV vaccination in a randomized clinical trial in Costa Rica. Plos One. 8: e68329. PMID 23873171 DOI: 10.1371/journal.pone.0068329  0.32
2013 Chang YJ, Chen HC, Pan MH, Lee BH, You SL, Lin CY, Chou YC, Hsieh CY, Cheng YJ, Liaw KL, Hsing AW, Schiffman M, Chen CJ. Intratypic variants of human papillomavirus type 16 and risk of cervical neoplasia in Taiwan. Journal of Medical Virology. 85: 1567-76. PMID 23852681 DOI: 10.1002/jmv.23651  0.32
2013 Rodríguez AC, Solomon D, Herrero R, Hildesheim A, González P, Wacholder S, Porras C, Jiménez S, Schiffman M. Impact of human papillomavirus vaccination on cervical cytology screening, colposcopy, and treatment. American Journal of Epidemiology. 178: 752-60. PMID 23843026 DOI: 10.1093/aje/kwt047  0.32
2013 Clarke M, Schiffman M, Wacholder S, Rodriguez AC, Hildesheim A, Quint W. A prospective study of absolute risk and determinants of human papillomavirus incidence among young women in Costa Rica. Bmc Infectious Diseases. 13: 308. PMID 23834901 DOI: 10.1186/1471-2334-13-308  0.32
2013 Luhn P, Houldsworth J, Cahill L, Schiffman M, Castle PE, Zuna RE, Dunn ST, Gold MA, Walker J, Wentzensen N. Chromosomal gains measured in cytology samples from women with abnormal cervical cancer screening results. Gynecologic Oncology. 130: 595-600. PMID 23769811 DOI: 10.1016/j.ygyno.2013.06.005  0.32
2013 Massad LS, Einstein MH, Huh WK, Katki HA, Kinney WK, Schiffman M, Solomon D, Wentzensen N, Lawson HW. 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. Obstetrics and Gynecology. 121: 829-46. PMID 23635684 DOI: 10.1097/AOG.0b013e3182883a34  0.32
2013 Gage JC, Schiffman M, Solomon D, Wheeler CM, Gravitt PE, Castle PE, Wentzensen N. Risk of precancer determined by HPV genotype combinations in women with minor cytologic abnormalities. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 22: 1095-101. PMID 23603204 DOI: 10.1158/1055-9965.EPI-12-1455  0.32
2013 Wilson LE, Pawlita M, Castle PE, Waterboer T, Sahasrabuddhe V, Gravitt PE, Schiffman M, Wentzensen N. Natural immune responses against eight oncogenic human papillomaviruses in the ASCUS-LSIL Triage Study. International Journal of Cancer. Journal International Du Cancer. 133: 2172-81. PMID 23588935 DOI: 10.1002/ijc.28215  0.32
2013 Safaeian M, Kemp TJ, Pan DY, Porras C, Rodriguez AC, Schiffman M, Cortes B, Katki H, Wacholder S, Schiller JT, Gonzalez P, Penrose K, Lowy DR, Quint W, van Doorn LJ, et al. Cross-protective vaccine efficacy of the bivalent HPV vaccine against HPV31 is associated with humoral immune responses: results from the Costa Rica Vaccine Trial. Human Vaccines & Immunotherapeutics. 9: 1399-406. PMID 23571174 DOI: 10.4161/hv.24340  0.32
2013 Schiffman M, Wentzensen N. Human papillomavirus infection and the multistage carcinogenesis of cervical cancer Cancer Epidemiology Biomarkers and Prevention. 22: 553-560. PMID 23549399 DOI: 10.1158/1055-9965.EPI-12-1406  0.32
2013 Killela PJ, Reitman ZJ, Jiao Y, Bettegowda C, Agrawal N, Diaz LA, Friedman AH, Friedman H, Gallia GL, Giovanella BC, Grollman AP, He TC, He Y, Hruban RH, Jallo GI, ... ... Schiffman M, et al. TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal. Proceedings of the National Academy of Sciences of the United States of America. 110: 6021-6. PMID 23530248 DOI: 10.1073/pnas.1303607110  0.32
2013 Katki HA, Schiffman M, Castle PE, Fetterman B, Poitras NE, Lorey T, Cheung LC, Raine-Bennett T, Gage JC, Kinney WK. Five-year risk of recurrence after treatment of CIN 2, CIN 3, or AIS: performance of HPV and Pap cotesting in posttreatment management. Journal of Lower Genital Tract Disease. 17: S78-84. PMID 23519309 DOI: 10.1097/LGT.0b013e31828543c5  0.32
2013 Katki HA, Gage JC, Schiffman M, Castle PE, Fetterman B, Poitras NE, Lorey T, Cheung LC, Raine-Bennett T, Kinney WK. Follow-up testing after colposcopy: five-year risk of CIN 2+ after a colposcopic diagnosis of CIN 1 or less. Journal of Lower Genital Tract Disease. 17: S69-77. PMID 23519308 DOI: 10.1097/LGT.0b013e31828543b1  0.32
2013 Katki HA, Schiffman M, Castle PE, Fetterman B, Poitras NE, Lorey T, Cheung LC, Raine-Bennett T, Gage JC, Kinney WK. Five-year risk of CIN 3+ to guide the management of women aged 21 to 24 years. Journal of Lower Genital Tract Disease. 17: S64-8. PMID 23519307 DOI: 10.1097/LGT.0b013e3182854399  0.32
2013 Katki HA, Schiffman M, Castle PE, Fetterman B, Poitras NE, Lorey T, Cheung LC, Raine-Bennett T, Gage JC, Kinney WK. Five-year risks of CIN 3+ and cervical cancer among women who test Pap-negative but are HPV-positive. Journal of Lower Genital Tract Disease. 17: S56-63. PMID 23519306 DOI: 10.1097/LGT.0b013e318285437b  0.32
2013 Katki HA, Schiffman M, Castle PE, Fetterman B, Poitras NE, Lorey T, Cheung LC, Raine-Bennett T, Gage JC, Kinney WK. Five-year risks of CIN 3+ and cervical cancer among women with HPV-positive and HPV-negative high-grade Pap results. Journal of Lower Genital Tract Disease. 17: S50-5. PMID 23519305 DOI: 10.1097/LGT.0b013e3182854282  0.32
2013 Katki HA, Schiffman M, Castle PE, Fetterman B, Poitras NE, Lorey T, Cheung LC, Raine-Bennett T, Gage JC, Kinney WK. Five-year risks of CIN 2+ and CIN 3+ among women with HPV-positive and HPV-negative LSIL Pap results. Journal of Lower Genital Tract Disease. 17: S43-9. PMID 23519304 DOI: 10.1097/LGT.0b013e3182854269  0.32
2013 Katki HA, Schiffman M, Castle PE, Fetterman B, Poitras NE, Lorey T, Cheung LC, Raine-Bennett T, Gage JC, Kinney WK. Five-year risks of CIN 3+ and cervical cancer among women with HPV testing of ASC-US Pap results. Journal of Lower Genital Tract Disease. 17: S36-42. PMID 23519303 DOI: 10.1097/LGT.0b013e3182854253  0.32
2013 Katki HA, Schiffman M, Castle PE, Fetterman B, Poitras NE, Lorey T, Cheung LC, Raine-Bennett T, Gage JC, Kinney WK. Benchmarking CIN 3+ risk as the basis for incorporating HPV and Pap cotesting into cervical screening and management guidelines. Journal of Lower Genital Tract Disease. 17: S28-35. PMID 23519302 DOI: 10.1097/LGT.0b013e318285423c  0.32
2013 Massad LS, Einstein MH, Huh WK, Katki HA, Kinney WK, Schiffman M, Solomon D, Wentzensen N, Lawson HW. 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. Journal of Lower Genital Tract Disease. 17: S1-S27. PMID 23519301 DOI: 10.1097/LGT.0b013e318287d329  0.32
2013 Gage JC, Schiffman M, Hunt WC, Joste N, Ghosh A, Wentzensen N, Wheeler CM. Cervical histopathology variability among laboratories: a population-based statewide investigation. American Journal of Clinical Pathology. 139: 330-5. PMID 23429369 DOI: 10.1309/AJCPSD3ZXJXP7NNB  0.32
2013 Lamere BJ, Castle PE, Fetterman B, Poitras N, Stanley M, Shieh J, Lorey T, Kinney W, Schiffman M. A study of borderline positive Hybrid Capture 2 tests in the Kaiser Permanente Northern California cervical screening program: evidence against retesting. Journal of Virological Methods. 189: 77-9. PMID 23384678 DOI: 10.1016/j.jviromet.2013.01.011  0.32
2013 Ajenifuja KO, Gage JC, Adepiti AC, Wentzensen N, Eklund C, Reilly M, Hutchinson M, Burk RD, Schiffman M. A population-based study of visual inspection with acetic acid (VIA) for cervical screening in rural Nigeria. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. 23: 507-12. PMID 23354369 DOI: 10.1097/IGC.0b013e318280f395  0.32
2013 Lin SW, Ghosh A, Porras C, Markt SC, Rodriguez AC, Schiffman M, Wacholder S, Kemp TJ, Pinto LA, Gonzalez P, Wentzensen N, Esser MT, Matys K, Meuree A, Quint W, et al. HPV16 seropositivity and subsequent HPV16 infection risk in a naturally infected population: comparison of serological assays. Plos One. 8: e53067. PMID 23301022 DOI: 10.1371/journal.pone.0053067  0.32
2013 Jemal A, Simard EP, Dorell C, Noone AM, Markowitz LE, Kohler B, Eheman C, Saraiya M, Bandi P, Saslow D, Cronin KA, Watson M, Schiffman M, Henley SJ, Schymura MJ, et al. Annual Report to the Nation on the Status of Cancer, 1975-2009, featuring the burden and trends in human papillomavirus(HPV)-associated cancers and HPV vaccination coverage levels. Journal of the National Cancer Institute. 105: 175-201. PMID 23297039 DOI: 10.1093/jnci/djs491  0.32
2012 Moscicki AB, Schiffman M, Burchell A, Albero G, Giuliano AR, Goodman MT, Kjaer SK, Palefsky J. Updating the natural history of human papillomavirus and anogenital cancers. Vaccine. 30: F24-33. PMID 23199964 DOI: 10.1016/j.vaccine.2012.05.089  0.32
2012 Franco EL, de Sanjosé S, Broker TR, Stanley MA, Chevarie-Davis M, Isidean SD, Schiffman M. Human papillomavirus and cancer prevention: Gaps in knowledge and prospects for research, policy, and advocacy Vaccine. 30: F175-F182. PMID 23199961 DOI: 10.1016/j.vaccine.2012.06.092  0.32
2012 Castle PE, Gravitt PE, Wentzensen N, Schiffman M. A descriptive analysis of prevalent vs incident cervical intraepithelial neoplasia grade 3 following minor cytologic abnormalities. American Journal of Clinical Pathology. 138: 241-6. PMID 22904136 DOI: 10.1309/AJCPNTK6G2PXWHOO  0.32
2012 Wentzensen N, Gravitt PE, Long R, Schiffman M, Dunn ST, Carreon JD, Allen RA, Gunja M, Zuna RE, Sherman ME, Gold MA, Walker JL, Wang SS. Human papillomavirus load measured by Linear Array correlates with quantitative PCR in cervical cytology specimens. Journal of Clinical Microbiology. 50: 1564-70. PMID 22337992 DOI: 10.1128/JCM.06240-11  0.32
2012 Marks MA, Castle PE, Schiffman M, Gravitt PE. Evaluation of any or type-specific persistence of high-risk human papillomavirus for detecting cervical precancer. Journal of Clinical Microbiology. 50: 300-6. PMID 22162556 DOI: 10.1128/JCM.05979-11  0.32
2011 Gage JC, Partridge EE, Rausa A, Gravitt PE, Wacholder S, Schiffman M, Scarinci I, Castle PE. Comparative performance of human papillomavirus DNA testing using novel sample collection methods. Journal of Clinical Microbiology. 49: 4185-9. PMID 21998422 DOI: 10.1128/JCM.01254-11  0.32
2011 Chen Z, Schiffman M, Herrero R, Desalle R, Anastos K, Segondy M, Sahasrabuddhe VV, Gravitt PE, Hsing AW, Burk RD. Evolution and taxonomic classification of human papillomavirus 16 (HPV16)-related variant genomes: HPV31, HPV33, HPV35, HPV52, HPV58 and HPV67. Plos One. 6: e20183. PMID 21673791 DOI: 10.1371/journal.pone.0020183  0.32
2011 Castle PE, Gutierrez EC, Leitch SV, Maus CE, McMillian RA, Nussbaumer WA, Vaughan LM, Wheeler CM, Gravitt PE, Schiffman M. Evaluation of a new DNA test for detection of carcinogenic human papillomavirus. Journal of Clinical Microbiology. 49: 3029-32. PMID 21632892 DOI: 10.1128/JCM.00422-11  0.32
2010 Wentzensen N, Wilson LE, Wheeler CM, Carreon JD, Gravitt PE, Schiffman M, Castle PE. Hierarchical clustering of human papilloma virus genotype patterns in the ASCUS-LSIL triage study. Cancer Research. 70: 8578-86. PMID 20959485 DOI: 10.1158/0008-5472.CAN-10-1188  0.32
2010 Castle PE, Schiffman M, Wheeler CM, Wentzensen N, Gravitt PE. Human papillomavirus genotypes in cervical intraepithelial neoplasia grade 3. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 19: 1675-81. PMID 20615885 DOI: 10.1158/1055-9965.EPI-10-0251  0.32
2010 Castle PE, Schiffman M, Wheeler CM, Wentzensen N, Gravitt PE. Impact of improved classification on the association of human papillomavirus with cervical precancer. American Journal of Epidemiology. 171: 155-63. PMID 20007673 DOI: 10.1093/aje/kwp390  0.32
2008 Castle PE, Porras C, Quint WG, Rodriguez AC, Schiffman M, Gravitt PE, González P, Katki HA, Silva S, Freer E, Van Doorn LJ, Jiménez S, Herrero R, Hildesheim A. Comparison of two PCR-based human papillomavirus genotyping methods. Journal of Clinical Microbiology. 46: 3437-45. PMID 18716224 DOI: 10.1128/JCM.00620-08  0.32
2008 Castle PE, Solomon D, Wheeler CM, Gravitt PE, Wacholder S, Schiffman M. Human papillomavirus genotype specificity of hybrid capture 2. Journal of Clinical Microbiology. 46: 2595-604. PMID 18579716 DOI: 10.1128/JCM.00824-08  0.32
2008 Gravitt PE, Schiffman M, Solomon D, Wheeler CM, Castle PE. A comparison of linear array and hybrid capture 2 for detection of carcinogenic human papillomavirus and cervical precancer in ASCUS-LSIL triage study. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 17: 1248-54. PMID 18483347 DOI: 10.1158/1055-9965.EPI-07-2904  0.32
2008 Castle PE, Cox JT, Jeronimo J, Solomon D, Wheeler CM, Gravitt PE, Schiffman M. An analysis of high-risk human papillomavirus DNA-negative cervical precancers in the ASCUS-LSIL Triage Study (ALTS). Obstetrics and Gynecology. 111: 847-56. PMID 18378743 DOI: 10.1097/AOG.0b013e318168460b  0.32
2008 Castle PE, Gravitt PE, Solomon D, Wheeler CM, Schiffman M. Comparison of linear array and line blot assay for detection of human papillomavirus and diagnosis of cervical precancer and cancer in the atypical squamous cell of undetermined significance and low-grade squamous intraepithelial lesion triage study. Journal of Clinical Microbiology. 46: 109-17. PMID 17989194 DOI: 10.1128/JCM.01667-07  0.32
2007 Gravitt PE, Kovacic MB, Herrero R, Schiffman M, Bratti C, Hildesheim A, Morales J, Alfaro M, Sherman ME, Wacholder S, Rodriguez AC, Burk RD. High load for most high risk human papillomavirus genotypes is associated with prevalent cervical cancer precursors but only HPV16 load predicts the development of incident disease International Journal of Cancer. 121: 2787-2793. PMID 17722112 DOI: 10.1002/ijc.23012  0.32
2007 Gravitt PE, van Doorn LJ, Quint W, Schiffman M, Hildesheim A, Glass AG, Rush BB, Hellman J, Sherman ME, Burk RD, Wang SS. Human papillomavirus (HPV) genotyping using paired exfoliated cervicovaginal cells and paraffin-embedded tissues to highlight difficulties in attributing HPV types to specific lesions. Journal of Clinical Microbiology. 45: 3245-50. PMID 17699644 DOI: 10.1128/JCM.00216-07  0.32
2005 Zelmanowicz Ade M, Schiffman M, Herrero R, Goldstein AM, Sherman ME, Burk RD, Gravitt P, Viscidi R, Schwartz P, Barnes W, Mortel R, Silverberg SG, Buckland J, Hildesheim A. Family history as a co-factor for adenocarcinoma and squamous cell carcinoma of the uterine cervix: results from two studies conducted in Costa Rica and the United States. International Journal of Cancer. Journal International Du Cancer. 116: 599-605. PMID 15818615 DOI: 10.1002/ijc.21048  0.32
2003 Sherman ME, Wang SS, Wheeler CM, Rich L, Gravitt PE, Tarone R, Schiffman M. Determinants of Human Papillomavirus Load among Women with Histological Cervical Intraepithelial Neoplasia 3: Dominant Impact of Surrounding Low-Grade Lesions Cancer Epidemiology Biomarkers and Prevention. 12: 1038-1044. PMID 14578140  0.32
2003 Gravitt PE, Burk RD, Lorincz A, Herrero R, Hildesheim A, Sherman ME, Bratti MC, Rodriguez AC, Helzlsouer KJ, Schiffman M. A comparison between real-time polymerase chain reaction and hybrid capture 2 for human papillomavirus DNA quantitation. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 12: 477-84. PMID 12814990  0.32
2003 Gravitt PE, Hildesheim A, Herrero R, Schiffman M, Sherman ME, Bratti MC, Rodriguez AC, Morera LA, Cardenas F, Bowman FP, Shah KV, Crowley-Nowick PA. Correlates of IL-10 and IL-12 concentrations in cervical secretions. Journal of Clinical Immunology. 23: 175-83. PMID 12797539 DOI: 10.1023/A:1023305827971  0.32
2002 Castle PE, Schiffman M, Gravitt PE, Kendall H, Fishman S, Dong H, Hildesheim A, Herrero R, Concepcion Bratti M, Sherman ME, Lorincz A, Schussler JE, Burk RD. Comparisons of HPV DNA detection by MY09/11 PCR methods Journal of Medical Virology. 68: 417-423. PMID 12226831 DOI: 10.1002/jmv.10220  0.32
2002 Lorincz AT, Castle PE, Sherman ME, Scott DR, Glass AG, Wacholder S, Rush BB, Gravitt PE, Schussler JE, Schiffman M. Viral load of human papillomavirus and risk of CIN3 or cervical cancer. Lancet. 360: 228-9. PMID 12133661 DOI: 10.1016/S0140-6736(02)09463-1  0.32
Show low-probability matches.